• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » DBT for Borderline Personality Disorder: Is Half the “Dose” Effective?
Research Update

DBT for Borderline Personality Disorder: Is Half the “Dose” Effective?

October 3, 2023
Kate J. Travis, MD
From The Carlat Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Kate Travis, MD. Dr. Travis has no financial relationships with companies related to this material.

REVIEW OF: McMain S et al, Psychother Psychosom 2022;91(6):382–397

STUDY TYPE: Randomized single-blind controlled trial

Most effective psychotherapies for borderline personality disorder (BPD) are long term, including dialectical behavior therapy (DBT). Many programs require patients to agree to a full year of DBT, which is a big commitment. If DBT could be provided in fewer sessions, we could help more patients with BPD—but would a briefer course of DBT be effective? This study attempted to answer this question by comparing six versus 12 months of DBT for patients with BPD.

The researchers randomized 240 patients with BPD from two sites in Canada to receive either six months of DBT (DBT-6) or the standard treatment of 12 months (DBT-12). Patients were mostly women (79%) with a mean age of 28 years and had to have a recent history of suicidal or nonsuicidal self-injurious episodes to be enrolled. The two therapies were identical except for length of treatment, with DBT-6 concluding after six months in half of the number of sessions. Both therapies involved the standard components of comprehensive DBT, including weekly individual therapy, weekly group skills training, 24/7 phone coaching, and consultation meetings for therapists. The primary outcome was total frequency of self-harm episodes during the previous three-month period, including suicidal and nonsuicidal self-injurious episodes, which was assessed by the Suicide Attempt Self-Injury Interview at baseline and every three months for up to 24 months. 

The two treatments did not differ significantly on the primary outcome of self-harm events. At the beginning of the study, the mean number of self-harm events per patient in the preceding three months was 7.39. By month 12 of treatment (end of treatment for DBT-12 and six months post-treatment for DBT-6), mean self-harm events in the preceding three months had dropped to 0.30 (DBT-12) and 0.26 (DBT-6) (no significant difference). Mean self-harm events continued to decrease for both groups and were 0.22 (DBT-12) and 0.10 (DBT-6) at month 24. Dropout rates were similar for both groups. Secondary analyses were also encouraging but somewhat mixed, with DBT-12 patients having more improvement in measures of interpersonal functioning and anger expression at month 24, but similar improvements in most other measures.

The study had several limitations. For one, there was no control arm such as a waitlist group to control for the passage of time and other independent variables. The authors considered including a control arm but ruled against it for ethical reasons. Additionally, concomitant treatments such as pharmacotherapy were not controlled for, and the primary outcome was subject to bias by relying on self-reporting.

CARLAT TAKE

A shorter, six-month course of DBT may be as effective as a full year in reducing self-harm in BPD.

General Psychiatry Research Update
KEYWORDS borderline personality disorder major depressive disorder mood disorders SSRIs
    Kate J. Travis, MD

    Antipsychotic Dosing: Differences Between Bipolar Mania and Schizophrenia

    More from this author
    www.thecarlatreport.com
    Issue Date: October 3, 2023
    SUBSCRIBE NOW
    Table Of Contents
    Learning Objectives, Sleep, TCPR, October 2023
    Controlled Substances: Handling Red Flags
    Sleep Apnea in Psychiatry
    Pets and Your Psychiatric Practice
    Do Personality Traits Impact Antidepressant Efficacy?
    DBT for Borderline Personality Disorder: Is Half the “Dose” Effective?
    CME Post-Test, Sleep, TCPR, October 2023
    DOWNLOAD NOW
    Featured Book
    • MFB7e_Print_App_Access.png

      Medication Fact Book for Psychiatric Practice, Seventh Edition (2024) - Regular Bound Book

      The updated 2024 reference guide covering the most commonly prescribed medications in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2603816031.jpg
      General Psychiatry

      A Scam for Every Woman, Child, and Man: Part 2

      1 in 3 Americans were victims of online scams in the past year. Even when you know your patient is being scammed, it is hard to pull them out. We speak with Cathy Wilson about...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.